MARKET

SNYNF

SNYNF

Sanofi FR
OTCPK
86.40
+1.68
+1.98%
Closed 10:44 05/15 EDT
OPEN
86.40
PREV CLOSE
84.72
HIGH
86.40
LOW
86.40
VOLUME
100
TURNOVER
8.64K
52 WEEK HIGH
101.06
52 WEEK LOW
85.42
MARKET CAP
104.33B
P/E (TTM)
20.57
1D
5D
1M
3M
1Y
5Y
1D
Davis to become acting director of CDER after Hoeg exit, Bloomberg says
TipRanks · 21h ago
Real-World Dupixent Data in Canada: What Regeneron and Sanofi Investors Should Watch
TipRanks · 1d ago
Trump Trade: Nvidia CEO joins China trip, Diamantas tapped as acting FDA chief
TipRanks · 2d ago
FDA Commissioner Marty Makary resigns
TipRanks · 3d ago
Trump confirms Kyle Diamantas to be acting head of FDA
TipRanks · 3d ago
Trump Trade: Trump to suspend tariff-rate quotas on beef imports
TipRanks · 3d ago
Kennedy driving vast vaccine inquiry despite toned-down criticism, NYT says
TipRanks · 4d ago
Teva's CNS Portfolio Is Growing, But Valuation Is Stretched
Seeking Alpha · 5d ago
More
About SNYNF
Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.

Webull offers Sanofi SA stock information, including OTCPK: SNYNF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SNYNF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SNYNF stock methods without spending real money on the virtual paper trading platform.